It’s no secret that the release of new guidelines by the Pharmaceutical Research and Manufacturers of America (PhRMA) in 2009, and the subsequent passing of The Sunshine Act in 2010, drastically reduced the branding and promotional opportunities for pharmaceutical companies.

Developing products which fit into these guidelines — those which have educational value to patients, and void of personal gain for healthcare providers — has been a challenge for distributors with pharmaceutical companies. Unlike other PhRMA Compliant products — brochure dispensers, new patient kits, and so on — Focus has extended product benefits.

Our product can have a direct impact on a patient’s health, simply by ensuring they can read their medications and take the appropriate dosage each time. Through an independent legal review, it has been verified this product qualifies as a patient educational device, which excludes it from the reporting requirements mandated by The Sunshine Act. In addition, because most drug therapies are ingested with water, it creates a cost-effective, easy advertising avenue for the majority of pharmaceutical manufacturers.